COMPOSITION FOR CELL THERAPY OF SPINAL CORD INJURY WITH STEM CELL DERIVED FROM UMBILICAL CORD BLOOD

摘要

Provided is a cell therapy for treating a patient with spinal paraplegia, comprising transplanting stem cells into a spinal cord of a patient under complete exposure of the spinal cord, using an umbilical cord blood-derived stem cell. The cell therapy in accordance with the present invention is based on the condition that the histocompatibility antigens of a stem cell are identical with those of a patient and thus can solve the problems associated with immune rejection without use of immunosuppressant drugs. Further, it is advantageous in that unlike the cases in which any other embryonic stem cells are employed, the cell therapy of the present invention presents no possibility of teratoma or teratocarcinoma occurrence in the body, and thus it is expected that the cell therapy in accordance with the present invention will give promising hope of a possible treatment for spinal paraplegic patients.